16-2281429-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001089.3(ABCA3):​c.4116T>C​(p.Ser1372Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.913 in 1,613,668 control chromosomes in the GnomAD database, including 674,183 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.88 ( 59447 hom., cov: 32)
Exomes 𝑓: 0.92 ( 614736 hom. )

Consequence

ABCA3
NM_001089.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.158

Publications

24 publications found
Variant links:
Genes affected
ABCA3 (HGNC:33): (ATP binding cassette subfamily A member 3) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. The full transporter encoded by this gene may be involved in development of resistance to xenobiotics and engulfment during programmed cell death. [provided by RefSeq, Jul 2008]
ABCA3 Gene-Disease associations (from GenCC):
  • interstitial lung disease due to ABCA3 deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 16-2281429-A-G is Benign according to our data. Variant chr16-2281429-A-G is described in ClinVar as Benign. ClinVar VariationId is 162672.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.158 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.976 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001089.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABCA3
NM_001089.3
MANE Select
c.4116T>Cp.Ser1372Ser
synonymous
Exon 27 of 33NP_001080.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABCA3
ENST00000301732.10
TSL:1 MANE Select
c.4116T>Cp.Ser1372Ser
synonymous
Exon 27 of 33ENSP00000301732.5
ABCA3
ENST00000382381.7
TSL:1
c.3942T>Cp.Ser1314Ser
synonymous
Exon 26 of 32ENSP00000371818.3
ABCA3
ENST00000566200.1
TSL:3
n.637T>C
non_coding_transcript_exon
Exon 2 of 5

Frequencies

GnomAD3 genomes
AF:
0.881
AC:
134071
AN:
152130
Hom.:
59400
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.774
Gnomad AMI
AF:
0.977
Gnomad AMR
AF:
0.914
Gnomad ASJ
AF:
0.904
Gnomad EAS
AF:
0.999
Gnomad SAS
AF:
0.953
Gnomad FIN
AF:
0.957
Gnomad MID
AF:
0.915
Gnomad NFE
AF:
0.910
Gnomad OTH
AF:
0.893
GnomAD2 exomes
AF:
0.923
AC:
231790
AN:
251228
AF XY:
0.924
show subpopulations
Gnomad AFR exome
AF:
0.778
Gnomad AMR exome
AF:
0.943
Gnomad ASJ exome
AF:
0.908
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
0.958
Gnomad NFE exome
AF:
0.911
Gnomad OTH exome
AF:
0.916
GnomAD4 exome
AF:
0.917
AC:
1339502
AN:
1461420
Hom.:
614736
Cov.:
70
AF XY:
0.918
AC XY:
667028
AN XY:
726992
show subpopulations
African (AFR)
AF:
0.773
AC:
25876
AN:
33480
American (AMR)
AF:
0.941
AC:
42063
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.910
AC:
23796
AN:
26136
East Asian (EAS)
AF:
1.00
AC:
39692
AN:
39700
South Asian (SAS)
AF:
0.953
AC:
82224
AN:
86258
European-Finnish (FIN)
AF:
0.956
AC:
50699
AN:
53006
Middle Eastern (MID)
AF:
0.884
AC:
5100
AN:
5768
European-Non Finnish (NFE)
AF:
0.913
AC:
1015052
AN:
1111968
Other (OTH)
AF:
0.911
AC:
55000
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
7643
15285
22928
30570
38213
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21502
43004
64506
86008
107510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.881
AC:
134172
AN:
152248
Hom.:
59447
Cov.:
32
AF XY:
0.886
AC XY:
65964
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.774
AC:
32139
AN:
41504
American (AMR)
AF:
0.915
AC:
13987
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.904
AC:
3138
AN:
3472
East Asian (EAS)
AF:
0.999
AC:
5175
AN:
5180
South Asian (SAS)
AF:
0.952
AC:
4598
AN:
4828
European-Finnish (FIN)
AF:
0.957
AC:
10172
AN:
10628
Middle Eastern (MID)
AF:
0.912
AC:
268
AN:
294
European-Non Finnish (NFE)
AF:
0.910
AC:
61916
AN:
68024
Other (OTH)
AF:
0.894
AC:
1888
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
791
1582
2372
3163
3954
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
900
1800
2700
3600
4500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.888
Hom.:
110285
Bravo
AF:
0.874
Asia WGS
AF:
0.966
AC:
3360
AN:
3478
EpiCase
AF:
0.903
EpiControl
AF:
0.902

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Ser1372Ser in exon 27 of ABCA3: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 22.0% (968/4396) o f African American chromosomes from a broad population by the NHLBI Exome Sequen cing Project (http://evs.gs.washington.edu/EVS; dbSNP rs149532).

Interstitial lung disease due to ABCA3 deficiency Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
1.8
DANN
Benign
0.42
PhyloP100
-0.16
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149532; hg19: chr16-2331430; COSMIC: COSV57057418; API